ACET — ADICET BIO INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -1.91 | — | -1.82 | -1.99 | 2 | +1−1 |
| Mar 2027 | -1.53 | — | -0.97 | -2.10 | 2 | +2 |
| Jun 2027 | -1.43 | — | -0.97 | -1.88 | 2 | +2 |
| Sep 2027 | -1.35 | — | -0.98 | -1.71 | 2 | +1 |
| Dec 2027 | -1.22 | — | -0.67 | -1.77 | 2 | +2 |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -7.55 | — | -7.47 | -7.62 | 2 | +1−1 |
| Dec 2027 | -5.45 | — | -3.50 | -7.39 | 2 | +2 |
| Dec 2028 | -2.43 | — | -2.43 | -2.43 | 1 | +1 |
| Dec 2029 | -2.26 | — | -2.26 | -2.26 | 1 | +1 |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 54 SEC-registered investment managers reported holding ACET (ADICET BIO INC) in their latest 13F filings, with a combined reported value of $34.98M across 5.31M shares. That is -0.7% by share count (-35.85K shares) versus the previous quarter, while reported value moved -24.3%. Ownership is concentrated: the five largest holders account for 54.6% of reported value and the top ten for 74.1%.
Compared with the prior quarter, 5 opened new positions, 15 added to existing stakes, 16 trimmed, 8 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of ADICET BIO INC (ACET) include Balyasny Asset Management, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, ranked by reported 13F value among the 175 institutional holders on this page.
ACET is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 54 | 5.31M | $34.98M | -0.7% |
| Q2 2026 | 56 | 5.62M | $48.53M | -11.0% |
| Q1 2026 | 50 | 6.34M | $43.21M | +1.8% |
| Q4 2025 | 48 | 6.54M | $55.06M | -91.5% |
| Q3 2025 | 55 | 49.70M | $40.27M | +0.5% |
| Q2 2025 | 50 | 49.74M | $30.35M | -4.4% |
| Q1 2025 | 54 | 51.86M | $39.02M | -4.7% |
| Q4 2024 | 60 | 55.23M | $53.13M | -2.4% |
Over the 8 quarters shown, institutional share counts decreased 90% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (-91.5%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 932.62K | $6.66M | 0.07% | Hold | |
| 844.79K | $6.03M | 0.12% | Hold | |
| 366.22K | $2.61M | 0.00% | Add | |
| 724.14K | $2.24M | 0.00% | Add | |
| 214.84K | $1.53M | 0.00% | Reduce | |
| 203.80K | $1.46M | 0.00% | Hold | |
| 193.12K | $1.38M | 0.00% | Reduce | |
| 188.95K | $1.35M | 0.01% | Reduce | |
| 188.20K | $1.34M | 1.03% | Reduce | |
| 184.29K | $1.32M | 0.02% | Hold | |
| 118.20K | $843.93K | 0.00% | Add | |
| 93.81K | $669.82K | 0.14% | Hold | |
| 89.81K | $641.26K | 0.01% | Add | |
| 85.96K | $613.75K | 0.01% | Hold | |
| 84.85K | $606.16K | 0.00% | Reduce | |
| 72.92K | $520.61K | 0.00% | Reduce | |
| 69.23K | $494.34K | 0.00% | Reduce | |
| 64.00K | $456.96K | 0.63% | Add | |
| 62.50K | $446.25K | 0.02% | Hold | |
| 61.02K | $435.71K | 0.00% | Reduce | |
| 60.51K | $432.05K | 0.24% | Hold | |
| 50.67K | $361.78K | 0.00% | Hold | |
| 47.55K | $339.48K | 0.36% | Add | |
| 38.14K | $272.31K | 0.00% | Add | |
| 36.22K | $258.62K | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 932.62K | $8.06M | 0.07% | Reduce | |
| 844.79K | $7.30M | 0.15% | Reduce | |
| 626.57K | $5.41M | 0.00% | Hold | |
| 343.23K | $2.97M | 0.00% | Add | |
| 274.38K | $2.37M | 0.00% | Hold | |
| 265.94K | $2.30M | 0.00% | Add | |
| 245.52K | $2.12M | 1.40% | Add | |
| 203.80K | $1.76M | 0.01% | Hold | |
| 195.51K | $1.69M | 0.01% | New | |
| 184.29K | $1.59M | 0.02% | Hold | |
| 157.83K | $1.36M | 0.63% | Hold | |
| 96.84K | $836.69K | 0.00% | Add | |
| 95.63K | $826.70K | 0.00% | New | |
| 95.63K | $826.70K | 0.00% | Reduce | |
| 93.81K | $810.54K | 0.15% | Hold | |
| 85.96K | $742.69K | 0.01% | New | |
| 79.49K | $686.77K | 0.00% | New | |
| 78.00K | $673.94K | 0.01% | Add | |
| 70.56K | $609.65K | 0.00% | Add | |
| 62.50K | $540.00K | 0.02% | Hold | |
| 62.13K | $536.77K | 0.00% | Add | |
| 60.51K | $522.82K | 0.29% | Hold | |
| 50.89K | $439.71K | 0.42% | Reduce | |
| 50.67K | $437.79K | 0.00% | Add | |
| 38.58K | $333.35K | 0.01% | Hold |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.18M | $8.05M | 0.09% | Add | |
| 1.03M | $7.00M | 0.14% | Hold | |
| 626.57K | $4.27M | 0.00% | Hold | |
| 381.82K | $2.60M | 0.00% | Add | |
| 336.52K | $2.29M | 0.00% | New | |
| 313.12K | $2.13M | 0.01% | Reduce | |
| 274.38K | $1.87M | 0.00% | Hold | |
| 250.24K | $1.70M | 0.28% | Hold | |
| 232.59K | $1.58M | 0.00% | Reduce | |
| 221.96K | $1.51M | 0.90% | Add | |
| 203.80K | $1.39M | 0.00% | Hold | |
| 184.29K | $1.26M | 0.01% | Hold | |
| 157.83K | $1.07M | 0.50% | Hold | |
| 101.14K | $689.04K | 0.00% | Add | |
| 93.81K | $638.86K | 0.15% | Hold | |
| 62.50K | $425.62K | 0.02% | Hold | |
| 60.51K | $412.08K | 0.86% | Hold | |
| 56.00K | $381.36K | 0.40% | Add | |
| 53.83K | $366.56K | 0.03% | Reduce | |
| 52.90K | $360.25K | 0.00% | New | |
| 50.33K | $342.77K | 0.00% | New | |
| 43.67K | $297.37K | 0.00% | New | |
| 43.11K | $293.55K | 0.00% | Reduce | |
| 38.58K | $262.74K | 0.01% | Hold | |
| 38.37K | $261.29K | 0.00% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.03M | $8.66M | 0.18% | Reduce | |
| 948.25K | $7.98M | 0.08% | Reduce | |
| 626.57K | $5.28M | 0.00% | New | |
| 625.00K | $5.26M | 0.02% | New | |
| 291.28K | $2.45M | 0.00% | Reduce | |
| 274.38K | $2.31M | 0.00% | New | |
| 250.24K | $2.11M | 0.43% | New | |
| 242.94K | $2.05M | 0.00% | Reduce | |
| 234.51K | $1.97M | 0.00% | Reduce | |
| 220.01K | $1.85M | 1.43% | New | |
| 203.80K | $1.72M | 0.01% | Reduce | |
| 184.29K | $1.54M | 0.01% | Reduce | |
| 157.83K | $1.33M | 0.78% | New | |
| 144.80K | $1.22M | 0.00% | Reduce | |
| 128.65K | $1.08M | 0.08% | New | |
| 111.34K | $937.45K | 0.00% | Reduce | |
| 107.81K | $907.79K | 0.00% | Reduce | |
| 93.81K | $789.90K | 0.19% | New | |
| 88.86K | $748.27K | 0.00% | Reduce | |
| 62.50K | $526.25K | 0.04% | New | |
| 60.51K | $509.50K | 1.51% | Reduce | |
| 59.56K | $501.48K | 0.52% | New | |
| 56.35K | $474.47K | 0.01% | Reduce | |
| 55.72K | $469.19K | 0.00% | Add | |
| 38.58K | $324.86K | 0.02% | Reduce |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.45M | $9.27M | 0.24% | Hold | |
| 8.22M | $6.66M | 0.26% | Hold | |
| 7.54M | $6.11M | 0.07% | Hold | |
| 3.75M | $3.04M | 0.00% | Hold | |
| 3.27M | $2.65M | 0.00% | Hold | |
| 2.95M | $2.39M | 0.06% | Hold | |
| 1.83M | $1.48M | 0.00% | Add | |
| 968.18K | $784.42K | 0.11% | Hold | |
| 901.60K | $730.48K | 0.02% | Hold | |
| 854.57K | $692.37K | 0.00% | Add | |
| 780.98K | $632.75K | 0.00% | Add | |
| 706.33K | $572.44K | 0.00% | Hold | |
| 655.66K | $531.22K | 0.00% | Hold | |
| 617.32K | $500.15K | 0.02% | Hold | |
| 585.38K | $474.27K | 0.00% | Reduce | |
| 583.95K | $473.12K | 0.00% | Add | |
| 565.95K | $458.54K | 0.00% | Reduce | |
| 565.95K | $458.54K | 0.00% | Reduce | |
| 479.11K | $388.17K | 0.00% | Reduce | |
| 364.47K | $295.30K | 0.06% | Hold | |
| 300.05K | $243.10K | 0.09% | Reduce | |
| 300.00K | $243.06K | 0.00% | Add | |
| 244.19K | $197.84K | 0.00% | Reduce | |
| 186.20K | $150.86K | 0.00% | New | |
| 140.37K | $113.73K | 0.00% | Hold |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.45M | $6.98M | 0.18% | Hold | |
| 8.22M | $5.02M | 0.25% | Hold | |
| 7.54M | $4.60M | 0.08% | Hold | |
| 3.75M | $2.29M | 0.00% | Reduce | |
| 3.27M | $2.00M | 0.00% | Add | |
| 2.95M | $1.80M | 0.04% | Hold | |
| 1.88M | $1.15M | 0.01% | New | |
| 1.15M | $703.83K | 0.00% | Add | |
| 968.18K | $590.59K | 0.04% | Hold | |
| 901.60K | $549.98K | 0.01% | Hold | |
| 706.33K | $430.98K | 0.00% | Reduce | |
| 655.66K | $399.96K | 0.00% | Hold | |
| 617.32K | $376.56K | 0.02% | Hold | |
| 599.49K | $365.69K | 0.00% | Reduce | |
| 592.33K | $361.32K | 0.00% | Reduce | |
| 592.33K | $361.32K | 0.00% | Reduce | |
| 566.04K | $345.28K | 0.00% | Reduce | |
| 540.00K | $329.40K | 0.09% | Reduce | |
| 512.81K | $312.81K | 0.00% | Add | |
| 364.47K | $228.01K | 0.07% | Hold | |
| 313.11K | $191.00K | 0.08% | Add | |
| 289.94K | $176.86K | 0.05% | New | |
| 246.92K | $150.62K | 0.00% | Hold | |
| 244.78K | $149.31K | 0.00% | Reduce | |
| 150.00K | $91.50K | 0.00% | New |
New Positions (Q3 2026)
- Connor, Clark & Lunn Investment Management Ltd. 23.31K sh · $166.42K
- Engineers Gate Manager LP 12.95K sh · $92.46K
- Citigroup Inc 4.72K sh · $33.71K
- Rialto Wealth Management, LLC 61 sh · $436
- BARCLAYS PLC 3 sh · $21
Fully Exited (vs previous quarter)
- NEXTBio Capital Management LP sold 157.83K sh · $1.36M
- GEODE CAPITAL MANAGEMENT, LLC sold 95.63K sh · $826.70K
- Quadrature Capital Ltd sold 36.19K sh · $312.71K
- XTX Topco Ltd sold 24.28K sh · $209.81K
- Squarepoint Ops LLC sold 15.25K sh · $131.79K
- AXQ CAPITAL, LP sold 10.99K sh · $94.96K
- Jump Financial, LLC sold 10.94K sh · $94.54K
- Fidelity Management & Research (FMR) sold 6 sh · $52
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 932.62K | 932.62K | 1.18M | 948.25K | 7.54M | 7.54M | 7.54M | 7.54M | 7.54M | 7.54M | 7.54M | — | — | — | — | — | — | — | — | — |
| ORBIMED ADVISORS LLC | 844.79K | 844.79K | 1.03M | 1.03M | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M | 8.32M | 8.32M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 366.22K | 343.23K | 336.52K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Franklin Resources | 724.14K | 626.57K | 626.57K | 626.57K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 214.84K | 265.94K | 232.59K | 242.94K | 1.83M | 1.15M | 810.70K | 916.50K | 1.23M | 1.51M | 1.05M | 766.60K | 677.00K | 210.40K | 315.80K | 29.70K | — | 125.50K | — | — |
| Alyeska Investment Group, L.P. | 203.80K | 203.80K | 203.80K | 203.80K | 655.66K | 655.66K | 655.66K | 655.66K | 655.66K | 655.66K | 655.66K | — | — | — | — | — | — | — | — | — |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 193.12K | 274.38K | 274.38K | 274.38K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Schonfeld Strategic Advisors LLC | 188.95K | 195.51K | — | — | 479.11K | 1.88M | — | — | — | 29.60K | 1.13M | 200.10K | — | — | — | — | — | — | — | — |
| Stonepine Capital Management, LLC | 188.20K | 245.52K | 221.96K | 220.01K | — | — | 508.27K | 700.00K | 609.45K | 609.45K | 141.55K | — | — | — | — | — | — | — | — | — |
| Carlyle Group Inc. | 184.29K | 184.29K | 184.29K | 184.29K | 2.95M | 2.95M | 2.95M | 2.95M | 2.95M | 2.95M | 2.95M | 2.12M | 2.12M | — | — | — | — | — | — | — |
| UBS Group AG | 118.20K | 29.82K | 38.37K | 3.80K | 21.44K | 18.51K | 64.04K | 203.23K | 41.60K | 160.84K | 53.54K | 22.58K | 4.34K | 27 | — | 117.59K | 17.27K | — | 547 | 9.88K |
| DAFNA Capital Management LLC | 93.81K | 93.81K | 93.81K | 93.81K | — | 540.00K | 600.00K | 600.00K | 600.00K | 600.00K | 600.00K | — | 797.05K | — | — | — | — | — | — | — |
| Trexquant Investment LP | 89.81K | 78.00K | 43.67K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 85.96K | 85.96K | — | 56.35K | 901.60K | 901.60K | 901.60K | 1.03M | 851.60K | 191.30K | 129.80K | 54.80K | 249.20K | — | — | — | — | — | — | — |
| Geode Capital Management | 84.85K | 95.63K | 101.14K | 88.86K | 706.33K | 706.33K | 770.70K | 767.54K | 768.57K | 671.00K | 1.20M | 661.79K | 632.95K | 632.97K | 606.19K | 590.16K | 538.50K | 421.57K | 391.83K | 308.52K |
| Two Sigma Investments | 72.92K | 96.84K | 43.11K | 144.80K | 854.57K | 512.81K | 494.98K | 703.36K | 703.42K | 631.09K | 521.57K | 360.73K | 225.32K | 154.63K | — | — | 14.37K | 329.29K | 392.80K | 703.61K |
| Marshall Wace | 69.23K | 79.49K | — | — | 51.73K | — | — | 40.31K | 145.20K | 35.32K | — | — | 152.51K | — | 19.57K | — | 84.55K | 32.19K | — | — |
| Rangeley Capital, LLC | 64.00K | 50.89K | 56.00K | 25.00K | 75.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Burkehill Global Management, LP | 62.50K | 62.50K | 62.50K | 62.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 61.02K | 62.13K | 36.59K | 36.59K | 585.38K | 599.49K | 749.07K | 811.78K | 752.01K | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ACET?
As of 2026-Q3, 54 institutional funds reported holding ACET (ADICET BIO INC) in SEC 13F filings, with a combined reported value of $34.98M.
How many shares of ACET do institutions own?
13F filers reported 5.31M shares of ACET, worth $34.98M in aggregate at the end of 2026-Q3.
Is institutional ownership of ACET rising or falling?
Share counts moved -0.7% versus the prior quarter — distribution.
Who are the top institutional holders of ACET?
The largest 13F holders are Balyasny Asset Management, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, Commodore Capital LP, VANGUARD CAPITAL MANAGEMENT LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of ADICET BIO INC?
The major shareholders of ADICET BIO INC (ACET) by reported 13F value are Balyasny Asset Management, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, Commodore Capital LP, VANGUARD CAPITAL MANAGEMENT LLC, among 175 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.